Causal diagrams: pitfalls and tips E Suzuki, T Shinozaki, E Yamamoto Journal of epidemiology 30 (4), 153-162, 2020 | 71 | 2020 |
Re-evaluation of the comparative effectiveness of bootstrap-based optimism correction methods in the development of multivariable clinical prediction models K Iba, T Shinozaki, K Maruo, H Noma BMC Medical Research Methodology 21 (1), 1-14, 2021 | 55 | 2021 |
A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies Y Takeuchi, T Shinozaki, Y Matsuyama BMC medical research methodology 18 (1), 4, 2018 | 35 | 2018 |
Understanding marginal structural models for time-varying exposures: pitfalls and tips T Shinozaki, E Suzuki Journal of epidemiology 30 (9), 377-389, 2020 | 34 | 2020 |
Introduction to Matching in Case-Control and Cohort Studies M Iwagami, T Shinozaki Annals of Clinical Epidemiology 4 (2), 33-40, 2022 | 32 | 2022 |
Confidence intervals of prediction accuracy measures for multivariable prediction models based on the bootstrap‐based optimism correction methods H Noma, T Shinozaki, K Iba, S Teramukai, TA Furukawa Statistics in Medicine 40 (26), 5691-5701, 2021 | 29 | 2021 |
Brief report: doubly robust estimation of standardized risk difference and ratio in the exposed population T Shinozaki, Y Matsuyama Epidemiology 26 (6), 873-877, 2015 | 23 | 2015 |
Population attributable fraction in textbooks: Time to revise A Khosravi, M Nazemipour, T Shinozaki, MA Mansournia Global Epidemiology 3, 100062, 2021 | 21 | 2021 |
On hazard ratio estimators by proportional hazards models in matched-pair cohort studies T Shinozaki, MA Mansournia, Y Matsuyama Emerging themes in epidemiology 14, 1-14, 2017 | 18 | 2017 |
Effective prevention of cardiovascular disease and diabetes‐related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: Adjusting for treatment … T Shinozaki, Y Matsuyama, S Iimuro, H Umegaki, T Sakurai, A Araki, ... Geriatrics & gerontology international 12, 88-102, 2012 | 15 | 2012 |
Misuse of Regression Adjustment for Additional Confounders Following Insufficient Propensity Score Balancing T Shinozaki, M Nojima Epidemiology 30 (4), 541-548, 2019 | 12 | 2019 |
Analyzing intent-to-treat and per-protocol effects on safety outcomes using a medical information database: an application to the risk assessment of antibiotic-induced liver injury Y Takeuchi, T Shinozaki, H Kumamaru, T Hiramatsu, Y Matsuyama Expert opinion on drug safety 17 (11), 1071-1079, 2018 | 7 | 2018 |
Estimation of controlled direct effects in time‐varying treatments using structural nested mean models: application to a primary prevention trial for coronary events with … T Shinozaki, Y Matsuyama, Y Ohashi Statistics in medicine 33 (18), 3214-3228, 2014 | 6 | 2014 |
G‐estimation of structural nested restricted mean time lost models to estimate effects of time‐varying treatments on a failure time outcome Y Hagiwara, T Shinozaki, Y Matsuyama Biometrics 76 (3), 799-810, 2020 | 5 | 2020 |
Mediational g-formula for time-varying treatment and repeated-measured multiple mediators: Application to atorvastatin's effect on cardiovascular disease via cholesterol … S Yamamuro, T Shinozaki, S Iimuro, Y Matsuyama Statistical methods in medical research, 2021 | 4 | 2021 |
Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two-stage stochastic dynamic treatment regime approach. Y Hagiwara, T Shinozaki, H Mukai, Y Matsuyama Biometrics 77 (2), 702-714, 2021 | 4 | 2021 |
Hazard ratio estimators after terminating observation within matched pairs in sibling and propensity score matched designs T Shinozaki, MA Mansournia The International Journal of Biostatistics 15 (1), 20170103, 2019 | 2 | 2019 |
Re: Biases in Randomized Trials A Conversation Between Trialists and Epidemiologists T Shinozaki, Y Hagiwara, Y Matsuyama Epidemiology 28 (4), e40-e41, 2017 | 2 | 2017 |
Bias amplification in the g-computation algorithm for time-varying treatments: a case study of industry payments and prescription of opioid products K Inoue, A Goto, N Kondo, T Shinozaki BMC Medical Research Methodology 22 (1), 1-10, 2022 | 1 | 2022 |
Analysis on Real-World Data: An Overview T Shinozaki, Y Matsuyama Epidemiologic Research on Real-World Medical Data in Japan 2, 77-88, 2022 | | 2022 |